This inventor holds 2 USPTO granted patents and 6 published patent applications and 1 EPO patent. Top assignee: The Salk Institute. Active years: 2023-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2024
Title: Yuji Tsunekawa: Innovator in Genome Editing
Introduction
Yuji Tsunekawa is a prominent inventor based in Kobe, Japan. He has made significant contributions to the field of genome editing, particularly in non-dividing cells. With a total of 2 patents, his work is paving the way for advancements in genetic engineering.
Latest Patents
Tsunekawa's latest patents focus on methods and compositions for genome editing in non-dividing cells. These patents disclose homology-independent targeted integration methods that allow for the integration of an exogenous DNA sequence into the genome of a non-dividing cell. The methods involve contacting the non-dividing cell with a composition that includes a targeting construct comprising the exogenous DNA sequence and a targeting sequence, along with a complementary strand oligonucleotide homologous to the targeting sequence and a nuclease. This innovative approach alters the genome of the non-dividing cell, showcasing Tsunekawa's expertise in the field.
Career Highlights
Yuji Tsunekawa is currently associated with the Salk Institute, where he continues to push the boundaries of genetic research. His work has garnered attention for its potential applications in various fields, including medicine and biotechnology.
Collaborations
Throughout his career, Tsunekawa has collaborated with notable scientists such as Keiichiro Suzuki and Juan Carlos Izpisua Belmonte. These collaborations have further enriched his research and contributed to the advancement of genome editing technologies.
Conclusion
Yuji Tsunekawa's innovative work in genome editing is making a significant impact in the scientific community. His patents and collaborations highlight his dedication to advancing genetic research and its applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
